Lebensbedrohliche Komplikation durch Neurostimulator

Zusammenfassung

Wir berichten über eine 66-jährige neuro-urologische Patientin, die 3 Jahre nach Implantation eines Neuromodulators aufgrund einer Strangulation durch das Stimulationskabel eine Nekrose des Zäkums erlitt.

Abstract

We report on a 66-year-old neuro-urological female patient who, three years after implantation of a neurostimulator, experienced cecal necrosis due to strangulation caused by the cable of the device.

Schlüsselwörter

Neurostimulation - Komplikation - neurogene Blase - Therapieversager

Keywords

complications - neurogenic bladder - therapeutic failure - neurostimulation

Publication History

Received: 08 August 2022

Accepted: 08 August 2022

Article published online:
27 October 2022

• Literatur

• 1 Ismail S, Chartier-Kastler E, Perrouin-Verbe M-A. et al. Long-Term Functional Outcomes of S3 Sacral Neuromodulation for the Treatment of Idiopathic Overactive Bladder. Neuromodulation 2017; 20: 825-829 DOI: 10.1111/ner.12696. (PMID: 28967986)
• 2 Kessler TM, La Framboise D, Trelle S. et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol 2010; 58: 865-874 DOI: 10.1016/j.eururo.2010.09.024. (PMID: 20934242)
• 3 Gu Y. et al. Neuromodulation of the Pudendal Nerve Assisted by 3D Printed: A New Method of Neuromodulation for Lower Urinary Tract Dysfunction | Front Neurosci 2021. https://www.frontiersin.org/articles/10.3389/fnins.2021.619672/full#B17
• 4 Spinelli M, Malaguti S, Giardiello G. et al. A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data. Neurourol Urodyn 2005; 24: 305-309 DOI: 10.1002/nau.20118. (PMID: 15977260)
• 5 Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am 2005; 32: 11-18 DOI: 10.1016/j.ucl.2004.09.004. (PMID: 15698871)
• 6 de Groat WC, Tai C. Impact of Bioelectronic Medicine on the Neural Regulation of Pelvic Visceral Function. Bioelectron Med 2015; 2015: 25-36
• 7 Janssen DA, Martens FM, de Wall LL. et al. Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives Med Devices (Auckl). 2017; 10: 109-122 DOI: 10.2147/MDER.S115678.eCollection2017.
• 8 van Kerrebroeck PEV, van Voskuilen AC, Heesakkers JPFA. et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 2007; 178: 2029-2034
• 9 Nitti VW, patel A, Karram M. Diagnosis and management of overactive bladder: A review. J Obstet Gynaecol Res 2021; 47: 1654-1665 DOI: 10.1111/jog.14708. (PMID: 33592680)
• 10 Zhang Y, Ji F, Liu E. et al. Mechanism and Priority of Botulinum Neurotoxin A versus Sacral neuromodulation for refractory overactive bladder: A review. Urol Int 2021; 105: 929-934 DOI: 10.1159/000515991.
• 11 Karapanos L, Chon S-H, Kokx R. et al. A rare case of tined lead migration of InterStim device into the rectum with subsequent novel combined surgical-endoscopic removal technique. Turk J Urol 2020; 46: 492-495